Aug 07, 2017 20:06 pm UTC| Business
Tipifarnib demonstrates high level of clinical activity and durable partial responses in ongoing Phase 2 trial in HRAS mutant squamous cell head and neck cancers Management to host webcast and conference call today at...
Inphi Corporation Announces Second Quarter 2017 Results
Aug 07, 2017 20:06 pm UTC| Business
SANTA CLARA, Calif., Aug. 07, 2017 -- Inphi Corporation (NYSE:IPHI), a leader in high-speed data movement interconnects, today announced financial results for its second quarter ended June 30, 2017. GAAP Results ...
RigNet Announces Second Quarter 2017 Earnings Results
Aug 07, 2017 20:06 pm UTC| Business
Quarterly revenue of $49.2 million consisting of: -- Managed Services revenue of $43.1 million, -- Systems Integration and Automation (SIA) revenue of $6.1 million Quarterly GAAP Net Loss attributable to common...
Hallmark Financial Services, Inc. Announces Second Quarter 2017 Results
Aug 07, 2017 20:06 pm UTC| Business
FORT WORTH, Texas, Aug. 07, 2017 -- Hallmark Financial Services, Inc. (NASDAQ:HALL) today announced results for its second fiscal quarter ended June 30, 2017, including the following highlights: 2nd quarter 2017 net...
Gaia Reports Second Quarter 2017 Results
Aug 07, 2017 20:06 pm UTC| Business
BOULDER, Colo., Aug. 07, 2017 -- Gaia, Inc. (NASDAQ:GAIA), a conscious media company, reported financial results for the second quarter ended June 30, 2017. Second Quarter 2017 vs. Same Year-Ago Quarter 64%...
CytomX Announces Second Quarter 2017 Financial Results and Mid-Year Update Webcast Conference Call
Aug 07, 2017 20:06 pm UTC| Business
Strong Pipeline Momentum Continues Initiated Combination Arms in Phase 1/2 PROCLAIM-CX-072 Study Initiated Phase 1/2 PROCLAIM-CX-2009 Study SOUTH SAN FRANCISCO, Calif., Aug. 07, 2017 -- CytomX Therapeutics, Inc....
Tactile Systems Technology, Inc. Reports Second Quarter 2017 Financial Results; Updates 2017 Outlook
Aug 07, 2017 20:06 pm UTC| Business
MINNEAPOLIS, Aug. 07, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight